Clover Health Investments, Corp.
CLOVHealthcareNASDAQHealthcare Plans · Last scanned Oct 24, 2026
Scan Results
Daily timeframeClover Health Investments, Corp. At a $2.44B market cap, Clover Health Investments, Corp. ranks as a mid-cap company within healthcare. provides medicare advantage plans in the United States.
Market Cap
$2.44B
Beta
2.46
P/E (TTM)
—
P/E (Fwd)
30.67
EPS (TTM)
$-0.05
EPS (Fwd)
$0.15
ROE
-5.1%
ROA
-1.8%
Cash
$243.1M
Total Debt
$0
Free CF
$69.0M
52W Change
20.4%
Annual Financials
Cash vs Debt
Where CLOV stands vs its 150-day and 200-day moving averages
As of the October 20, 2026 close, CLOV finished 15.32% above its 150-day moving average ($3.85) and 28.70% above its 200-day moving average ($3.45). This snapshot is end-of-day data shown with a five-trading-day delay on the free plan; Premium members see readings from the latest close.
Is CLOV overbought or oversold?
At the October 20, 2026 close, CLOV's RSI(14) was 54.4, in neutral territory (between 30 and 70). The MACD histogram was negative, so short-term momentum leaned bearish at that close. These readings are historical, refresh daily after market close, and are not investment advice.
Clover Health Investments, Corp. reports $243.1M in cash and $0 in total debt. Annual free cash flow of $69.0M supports ongoing capital allocation decisions and provides a cushion against unexpected expenses or downturns. Return on equity stands at -5.1%, which is negative for the sector. ROE measures how effectively a company uses shareholder capital to generate profits. Revenue has grown from $1.10B (2022) to $1.92B (2025), reflecting a 75% increase over the period.
Clover Health Investments, Corp.'s elevated beta suggests the stock experiences more pronounced price movements than the overall market, which increases both upside potential and downside risk. No single metric tells the full story. Reviewing CLOV's risk profile alongside its fundamentals and technical indicators provides a more complete picture.